Are you Dr. Pak?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 25 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-0624Fax+1 214-645-0078- Is this information wrong?
Summary
- Dr. Charles Pak, MD is an internist in Dallas, Texas. He is currently licensed to practice medicine in Texas. He is a Clinical Professor at University of Texas Southwestern Medical Center.
Education & Training
- University of ChicagoResidency, Internal Medicine, 1961 - 1963
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1961
Certifications & Licensure
- TX State Medical License 1972 - 2024
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1972
Publications & Presentations
PubMed
- 10 citationsControl of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility studyHenry Quiñones, Tamim Hamdi, Khashayar Sakhaee, Andreas Pasch, Orson W. Moe, Charles Y.C. Pak> ;Journal of Nephrology. 2019 Feb 1
- 10 citationsEffects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive SubjectsWanpen Vongpatanasin, Alejandro Velasco, Debbie Arbique, Zhongyun Wang, Priya Ravikumar, Beverly Adams-Huet, Orson W. Moe, Charles Y.C. Pak> ;The American Journal of Cardiology. 2016 Sep 15
- 48 citationsAnimal Protein and the Risk of Kidney Stones: A Comparative Metabolic Study of Animal Protein SourcesChad R. Tracy, Sara L. Best, Aditya Bagrodia, John R. Poindexter, Beverly Adams-Huet, Khashayar Sakhaee, Naim M. Maalouf, Charles Y.C. Pak, Margaret S. Pearle> ;The Journal of Urology. 2014 Jul 1
- Join now to see all
Press Mentions
- Supplement Lowers Risk of Higher Glucose Caused by Blood-Pressure DrugDecember 1st, 2023
Grant Support
- Refined Alkali Treatment Of NephrolithiasisNational Institute Of Diabetes And Digestive And Kidney Diseases1996
- Core--General Analytical LaboratoryNational Institute Of Diabetes And Digestive And Kidney Diseases1996